Has Jessica Luther received payments from drug or device companies?

Yes. Drug and device makers reported $3,065 in general payments to Jessica Luther across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Luther did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Luther come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Luther

Family · Benton City, WANPI 1902291768

Payments from drug & device makers

$3,065in general payments, 2019–2025

Across 158 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
AstraZeneca$487
Pfizer$200
Boehringer Ingelheim$141
GSK$113
Otsuka America Pharmaceutical, Inc.$105
plus $733 from 17 others

What the payments were for

Food & beverage$3,065100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	77	$1,285
AstraZeneca	11	$487
Pfizer	18	$200
Boehringer Ingelheim	5	$141
GSK	6	$113
Otsuka America Pharmaceutical, Inc.	5	$105
Novo Nordisk	5	$90
Johnson & Johnson	3	$85
Merck	5	$85
Sanofi-aventis U.S. LLC	3	$73
Bayer	3	$70
Kyowa Kirin, Inc.	2	$55
Daiichi Sankyo Inc.	2	$51
Neurocrine Biosciences, Inc.	2	$46
Mylan Specialty L.p.	2	$33
Mimedx Group, Inc.	1	$25
Sunovion Pharmaceuticals Inc.	1	$25
Sanofi Pasteur Inc.	1	$23
Supernus Pharmaceuticals, Inc.	1	$17
Genentech USA, Inc.	2	$17
Viatris Specialty LLC	1	$16
Teva Pharmaceuticals USA, Inc.	1	$15
Phathom Pharmaceuticals, Inc.	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FARXIGA$241
UBRELVY$120
BREZTRI$102

How this compares

$3,065 in reported general payments places this provider in the 90th percentile of 1,706 family providers in Washington.

See all family providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	49	$45,381
JardianceEmpagliflozin	29	$43,619
FarxigaDapagliflozin Propanediol	26	$31,877
OzempicSemaglutide	14	$26,471
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	12	$5,704
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	25	$4,623
Albuterol Sulfate HfaAlbuterol Sulfate	90	$2,563
Levothyroxine Sodium	138	$1,204
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	54	$1,159
Atorvastatin Calcium	146	$1,153
Gabapentin	56	$1,124
Omeprazole	90	$1,113
Scopolamine	11	$1,080
Metoprolol Succinate	59	$1,071
Lisinopril	191	$985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$200	$45,38149 claims
Boehringer IngelheimJardiance	$141	$43,61929 claims
AstraZenecaFarxiga	$487	$31,87726 claims
Novo NordiskOzempic	$90	$26,47114 claims
GSKAnoro Ellipta	$113	$5,70412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,706 family providers in Washington.

Other family in Benton City

Patric SchineCentralia$842K
Sharla PetersonKenmore$192K
Zelda SwainSpokane$83K
Savannah MorganRenton$76K
Kevan PettersonSeattle$56K
Kelly McFeeSunnyside$42K
Cheryl SomersSpokane$31K
Hye-Jin GehringBellevue$30K
Kaitlin BrasierSeattle$29K
Karen JohnsonSeattle$16K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →